Fund profile
Tickers
PBE
Fund manager
Total assets
$267.04 mm
Liabilities
$56.39 mm
Net assets
$210.65 mm
Number of holdings
33.00
PBE stock data
33 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 40.40 mm | 40.40 mm shares | 19.18 | Short-term investment vehicle | Long | USA |
Invesco Private Government Fund | 15.71 mm | 15.71 mm shares | 7.46 | Short-term investment vehicle | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 12.41 mm | 34.28 k shares | 5.89 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 12.35 mm | 157.30 k shares | 5.86 | Common equity | Long | USA |
AMGN AMGEN Inc. | 11.92 mm | 46.62 k shares | 5.66 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 11.58 mm | 51.98 k shares | 5.50 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 11.14 mm | 14.29 k shares | 5.29 | Common equity | Long | USA |
BIIB Biogen Inc | 10.85 mm | 45.67 k shares | 5.15 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 10.81 mm | 132.66 k shares | 5.13 | Common equity | Long | USA |
INCY Incyte Corp. | 10.00 mm | 185.36 k shares | 4.75 | Common equity | Long | USA |
VCEL Vericel Corp | 7.05 mm | 200.27 k shares | 3.34 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 6.79 mm | 61.17 k shares | 3.22 | Common equity | Long | USA |
EXEL Exelixis Inc | 6.28 mm | 304.97 k shares | 2.98 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 6.23 mm | 438.18 k shares | 2.96 | Common equity | Long | USA |
MNKD Mannkind Corp | 6.19 mm | 1.44 mm shares | 2.94 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 5.88 mm | 377.13 k shares | 2.79 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 5.81 mm | 116.73 k shares | 2.76 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 5.76 mm | 525.32 k shares | 2.74 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 5.68 mm | 230.82 k shares | 2.69 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals Inc | 5.64 mm | 454.28 k shares | 2.68 | Common equity | Long | USA |
QGEN Qiagen NV | 5.54 mm | 148.07 k shares | 2.63 | Common equity | Long | Netherlands |
RGEN Repligen Corp. | 5.45 mm | 40.48 k shares | 2.59 | Common equity | Long | USA |
ALKS Alkermes plc | 5.37 mm | 222.14 k shares | 2.55 | Common equity | Long | Ireland |
VCYT Veracyte Inc | 5.22 mm | 252.05 k shares | 2.48 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 5.20 mm | 153.41 k shares | 2.47 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 5.08 mm | 225.19 k shares | 2.41 | Common equity | Long | USA |
CTLT Catalent Inc. | 5.07 mm | 147.51 k shares | 2.41 | Common equity | Long | USA |
XNCR Xencor Inc | 4.95 mm | 285.31 k shares | 2.35 | Common equity | Long | USA |
OPK Opko Health Inc | 4.82 mm | 3.85 mm shares | 2.29 | Common equity | Long | USA |
FLGT Fulgent Genetics Inc | 4.63 mm | 193.47 k shares | 2.20 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 3.94 mm | 637.85 k shares | 1.87 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 3.12 mm | 166.26 k shares | 1.48 | Common equity | Long | USA |
Invesco Government & Agency Portfolio, Institutional Class | 149.55 k | 149.55 k shares | 0.07 | Short-term investment vehicle | Long | USA |